Skip to main content

Find Clinical Trials

Home
Conditions
Cytomegalovirus Infections

Clinical trial condition

Cytomegalovirus Infections

Explore clinical trials studying Cytomegalovirus Infections. Study availability and eligibility vary by location and protocol.

284 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Cytomegalovirus Infections trial results

Completed

Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia

NCT03915366

Conditions: Acquired Immunodeficiency Syndrome, Actinomycetales Infections, Bacterial Infections, +27 more
Locations: Programme PACCI. Centre Hospitalier Cocody. Abidjan, Côte d’Ivoire

Université de Bourdeaux Bourdeaux, France

INSERM Toulouse, France

PENTA Foundation Padova, Italy

View all 13 locations

View Trial Details

Completed

Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation

NCT07181330

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation, CMV Reactivation, Cytomegalovirus Infections, +5 more
Locations: The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details

Completed

Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus

NCT01325636

Conditions: Adenoviridae Infections, Adenovirus Infections, Cytomegalovirus Infections, +4 more
Locations: Biotherapy department, Hôpital Necker - Enfants Malades Paris, France

View Trial Details

Completed

In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir

NCT01651585

Conditions: Cytomegalovirus (CMV)Infection, Cytomegalovirus Infections, DNA Virus Infections, +4 more
Locations: Hospital Necker Enfants Malades Paris, France

View Trial Details

Completed

Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero

NCT01923636

Conditions: Congenital Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations: Hôpital Necker Enfants Malades Paris, France

View Trial Details

Completed

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

NCT04017962

Conditions: CMV, CMV Infection, Cytomegalovirus Infections, +5 more
Locations: University of Minnesota Minneapolis, Minnesota, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Letermovir Use in Heart Transplant Recipients

NCT04904614

Conditions: Agranulocytosis, Antiviral Toxicity, Cytomegalovirus Disease, +12 more
Locations: Tufts Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

NCT04225923

Conditions: Cytomegalovirus Disease, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations: Mayo Clinic - Scottsdale Phoenix, Arizona, United States

California Institute of Renal Research La Mesa, California, United States

Piedmont Healthcare Atlanta, Georgia, United States

Augusta University Medical Center Augusta, Georgia, United States

View all 28 locations

View Trial Details

Completed

Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis

NCT02943057

Conditions: Cytomegalovirus Infections, DNA Virus Infections, Herpesviridae Infections, +2 more
Locations: Singapore National Eye Centre Singapore

View Trial Details

Completed

A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

NCT05763823

Conditions: Cytomegalovirus Infection, Cytomegalovirus Infections, DNA Virus Infections, +3 more
Locations: Anhui Provincial Hospital ( Site 0024) Hefei, Anhui, China

Peking University First Hospital ( Site 0009) Beijing, Beijing Municipality, China

Peking University People's Hospital-Hematology ( Site 0033) Beijing, Beijing Municipality, China

The Second Affiliated Hospital of Third Military Medical University-Oncology Department ( Site 0002) Chongqing, Chongqing Municipality, China

View all 21 locations

View Trial Details